SF3B1+/- mice accumulate RS in the bone marrow, which are rarely found in animal models of MDS, suggesting that SF3B1 haploinsufficiency causes biological features resembling low risk MDS-RS indicating that this mouse model could be a target for preclinical therapeutic studies (68). Here, SF3B1 is linked to myelodysplastic syndrome.